| Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike J Prévost, R Gasser, G Beaudoin-Bussières, J Richard, R Duerr, ... Cell Reports Medicine 1 (7), 2020 | 238 | 2020 |
| Single-cell characterization of viral translation-competent reservoirs in HIV-infected individuals AE Baxter, J Niessl, R Fromentin, J Richard, F Porichis, R Charlebois, ... Cell host & microbe 20 (3), 368-380, 2016 | 217 | 2016 |
| Effect of convalescent plasma on organ support–free days in critically ill patients with COVID-19: a randomized clinical trial H Abdelhady, M Abdelrazik, Z Abdi, D Abdo, A Abdulle, L Abel, ... Jama 326 (17), 1690-1702, 2021 | 208 | 2021 |
| The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals M Veillette, M Coutu, J Richard, LA Batraville, O Dagher, N Bernard, ... Journal of virology 89 (1), 545-551, 2015 | 200 | 2015 |
| HIV-1 Vpr up-regulates expression of ligands for the activating NKG2D receptor and promotes NK cell–mediated killing J Richard, S Sindhu, TNQ Pham, JP Belzile, ÉA Cohen Blood, The Journal of the American Society of Hematology 115 (7), 1354-1363, 2010 | 200 | 2010 |
| Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy I Ullah, J Prévost, MS Ladinsky, H Stone, M Lu, SP Anand, ... Immunity 54 (9), 2143-2158. e15, 2021 | 195 | 2021 |
| Decline of humoral responses against SARS-CoV-2 spike in convalescent individuals G Beaudoin-Bussières, A Laumaea, SP Anand, J Prévost, R Gasser, ... MBio 11 (5), 10.1128/mbio. 02590-20, 2020 | 188 | 2020 |
| Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset SP Anand, J Prévost, M Nayrac, G Beaudoin-Bussières, M Benlarbi, ... Cell Reports Medicine 2 (6), 2021 | 183 | 2021 |
| A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses A Tauzin, M Nayrac, M Benlarbi, SY Gong, R Gasser, ... Cell host & microbe 29 (7), 1137-1150. e6, 2021 | 174 | 2021 |
| CD4 mimetics sensitize HIV-1-infected cells to ADCC J Richard, M Veillette, N Brassard, SS Iyer, M Roger, L Martin, M Pazgier, ... Proceedings of the National Academy of Sciences 112 (20), E2687-E2694, 2015 | 144 | 2015 |
| A newly discovered antifibrotic pathway regulated by two fatty acid receptors: GPR40 and GPR84 L Gagnon, M Leduc, JF Thibodeau, MZ Zhang, B Grouix, F Sarra-Bournet, ... The American Journal of Pathology 188 (5), 1132-1148, 2018 | 133 | 2018 |
| Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2 R Gasser, M Cloutier, J Prévost, C Fink, É Ducas, S Ding, N Dussault, ... Cell reports 34 (9), 2021 | 115 | 2021 |
| Structural basis and mode of action for two broadly neutralizing antibodies against SARS-CoV-2 emerging variants of concern W Li, Y Chen, J Prévost, I Ullah, M Lu, SY Gong, A Tauzin, R Gasser, ... Cell reports 38 (2), 2022 | 111 | 2022 |
| A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection G Beaudoin-Bussières, Y Chen, I Ullah, J Prévost, WD Tolbert, K Symmes, ... Cell reports 38 (7), 2022 | 107 | 2022 |
| An asymmetric opening of HIV-1 envelope mediates antibody-dependent cellular cytotoxicity N Alsahafi, N Bakouche, M Kazemi, J Richard, S Ding, S Bhattacharyya, ... Cell host & microbe 25 (4), 578-587. e5, 2019 | 103 | 2019 |
| Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity SY Gong, D Chatterjee, J Richard, J Prévost, A Tauzin, R Gasser, Y Bo, ... Virology 563, 134-145, 2021 | 95 | 2021 |
| Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses A Tauzin, SY Gong, G Beaudoin-Bussières, D Vézina, R Gasser, L Nault, ... Cell host & microbe 30 (1), 97-109. e5, 2022 | 91 | 2022 |
| Uninfected bystander cells impact the measurement of HIV-specific antibody-dependent cellular cytotoxicity responses J Richard, J Prévost, AE Baxter, B von Bredow, S Ding, H Medjahed, ... MBio 9 (2), 10.1128/mbio. 00358-18, 2018 | 87 | 2018 |
| A broad HIV-1 inhibitor blocks envelope glycoprotein transitions critical for entry A Herschhorn, C Gu, N Espy, J Richard, A Finzi, JG Sodroski Nature chemical biology 10 (10), 845-852, 2014 | 86 | 2014 |
| Impact of HIV-1 envelope conformation on ADCC responses J Richard, J Prévost, N Alsahafi, S Ding, A Finzi Trends in microbiology 26 (4), 253-265, 2018 | 80 | 2018 |